Sunday, February 19, 2012
11:30 AM - 12:30 PM
Medications: Integrated, Long-term Treatment Strategies

Ira D. Glick, MD

Ira D. Glick, MD, Chief of the Schizophrenia Clinic at the Stanford University School of Medicine, has an extensive background in research, education and academic medicine. He has been a professor at three prestigious medical schools (UCSF, Cornell and Stanford), and as senior science advisor to the Director of the National Institute of Health (NIMH).

He is internationally recognized for his broad expertise in education, research, clinical care and as an ardent advocate for consumer organizations. As Chief of the Schizophrenia Service, he has embraced a clinical mission to provide each patient with the highest quality care including cutting-edge medication, psychotherapeutic support and family intervention.

In addition to being an NIMH science advisor, he chaired the Public-Academic Liaison Program (PAL) Research Program. He has also served on NIMH review committees and American Psychiatric Association research committees. He has been Chair of three American College of Neuropsychopharmacology committees including Education and Training, Finance as well as Constitution. He has been on he Boards of the American Society of Clinical Psychopharmacology and the American Family Therapy Academy. He is a founder and long-tome board member of the International Society for Sport Psychiatry.

Dr. Glick received his medical degree from New York Medical College in 1961. He received his Bachelor of Science degree from Dickinson College in 1957. He completed an internship at Beth Israel Hospital in NYC and residency training at Hillside Hospital and Mt. Zion Hospital in San Francisco.

He serves on numerous editorial boards, has written over 180 articles and chapters on psychiatric and academic medicine topics. He is the lead author for 1) the American Society of Clinical Psychopharmacology (ASCP) Model Curriculum in Psychopharmacology for psychiatric residents (now in its fourth edition), 2) the standard text for marital and family therapy (now in its fourth edition) and 3) the first paper on psychiatric treatment of elite athletes as well as psychiatric aspects of basketball. He has received more than 40 NIMH, foundation and industry research grants for studies of both medication and psychosocial treatment for psychiatric disorders.

He has negotiated and conducted international research and educational studies collaborating with a variety of countries including India, Italy, Indonesia, Japan, Uruguay, France, China and Argentina.

Dr. Glick has received numerous awards including separate awards for research, teaching and rehabilitation from the American Psychiatric Association; for research on schizophrenia from the American Psychological Foundation; for research on the family model from the American Family Therapy Academy (2001); the Lundbeck International Award for the curriculum (2006); Fulbright awards for research in Japan and Italy (1987), a Fulbright lectureship in India (2005), and a Rockefeller Residency Award (2002). In 2008 he received the American College of Psychiatry’s highest award – The Distinguished Service in Psychiatry Award and the Association of Academic Psychiatry’s Distinguished Life Fellowship status.

He has been a recipient of outstanding alumnus awards from his high school (1956), his college (2006) and his medical school (1991). He received the US Army Commendation Medal in 1966, and the Hoch Award from the American College of Neuropsychopharmacology for distinguished service to the organization (2005).